SCHEMBL7679598

SCHEMBL7679598

c1cc(CNCCN2CCNCC2)cc(N2CCOCC2)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.58
CYP2D6 P10635 2/20 0.58
ALDH1A1 P00352 2/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
CYP2C19 P33261 1/20 0.47
TNKS2 Q9H2K2 1/20 0.42
MAOB P27338 1/20 0.42
HTR6 P50406 1/20 0.42
AOC3 Q16853 1/20 0.42
SLC40A1 Q9NP59 1/20 0.42
NMT1 P30419 1/20 0.41
POLB P06746 1/20 0.41
PIK3CA P42336 1/20 0.41
PDGFRB P09619 1/20 0.41
KDR P35968 1/20 0.41
MAP4K4 O95819 1/20 0.40
CHEK1 O14757 1/20 0.40
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7681152 0.92 CYP2D6 (0.55) CYP3A4CYP2D6ALDH1A1L3MBTL1CYP2C19
SCHEMBL7677919 0.85 CYP2C19 (0.67) CYP3A4CYP2D6ALDH1A1CYP2C19SLC40A1
SCHEMBL7682114 0.83 CYP2C19 (0.60) CYP3A4CYP2D6ALDH1A1CYP2C19SLC40A1
SCHEMBL7679073 0.76 CYP3A4 (0.45) CYP3A4CYP2D6CYP2C19SLC40A1PIK3CA
SCHEMBL10210050 0.75 PIK3CA (0.50) TSHRPIK3CAKDM4EMAPTPIK3CB
SCHEMBL10154083 0.75 PIK3CA (0.50) CYP3A4ALDH1A1TSHRCYP2C19PIK3CA
SCHEMBL15329158 0.75 CYP3A4 (1.00) CYP3A4CYP2D6ALDH1A1ALOX15TSHR
SCHEMBL24455071 0.72 RAB9A (0.53) ALDH1A1CYP2C19PIK3CAKDM4ELMNA
SCHEMBL29561895 0.72 RAB9A (0.53) ALDH1A1CYP2C19PIK3CAKDM4ELMNA
SCHEMBL2459118 0.70 PIK3CA (0.54) CYP2C19PIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6455520-B1 TUMOR NECROSIS FACTOR AND INTERLEUKIN INHIBITORS; ANTIINFLAMMATORY AGENTS, ANTIALLERGENS; BONE DISORDERS ASTRA ZENECA AB (SE) 2002-09-24 US disclosed